{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T06:06:37Z","timestamp":1791439597875,"version":"4.3.3"},"reference-count":49,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Sanming Project of Medicine in Shenzen Municipality","award":["SZZYSM202311001"],"award-info":[{"award-number":["SZZYSM202311001"]}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82505212"],"award-info":[{"award-number":["82505212"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000087","name":"The 2025 Annual Basic and Applied Fundamental Research Topics-Young Doctor \"Launch\" Program","doi-asserted-by":"publisher","award":["2025A04J4194"],"award-info":[{"award-number":["2025A04J4194"]}],"id":[{"id":"10.13039\/100000087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pulmonary fibrosis is a severe chronic lung disease whose prevalence has been rising in recent years, representing one of the major respiratory health challenges globally in the 21st century. The burden of this disease on the elderly population is garnering growing attention, particularly as the global population ages. The Global Burden of Disease (GBD) study has provided valuable insights; however, systematic analyses focused on this condition remain limited. To date, few studies have specifically examined interstitial lung disease and pulmonary sarcoidosis among individuals aged 55 years and older. This study aims to conduct a comprehensive analysis of burden trends from 1990 to 2021 for those aged 55 and above and to project future trends up to 2035.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Our approach utilizes the estimation of four broad component measures: incidence, prevalence, death and Disability-Adjusted Life Years (DALYs), using data on ILD&amp;PS from the Global Burden of Disease (GBD) 2021 database. Joinpoint regression models were applied to calculate the average annual percentage change (AAPC) in order to analyze temporal trends in disease burden and to identify years with significant trend shifts. Analyses were further stratified by age, sex, region, country, and Sociodemographic Index (SDI). Additionally, a Bayesian age-period-cohort (BAPC) model was used to project future disease burden trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Between 1990 and 2021, significant increases were observed in incidence, DALYs, and death rates for ILD&amp;PS (AAPC incidence\u2009=\u20091.09, 95% CI: 1.04 to 1.15; AAPC DALYs\u2009=\u20091.10, 95% CI: 0.97 to 1.23; AAPC death\u2009=\u20091.65, 95% CI: 1.47 to 1.83). In 2021, the total number of incident cases reached 284,887 (95% UI 248,300\u2013328,800), with the highest incidence rates observed in Andean Latin America. Across age- and sex-specific analyses, global burden trends were similar, though males consistently exhibited higher rates than females. The oldest age group (95\u2009+\u2009years) had the highest incidence and DALYs rates among all age strata. Furthermore, incidence rates increased most markedly in high-SDI regions, showing a strong positive correlation between SDI and incidence. Bayesian age\u2013period\u2013cohort (BAPC) analyses indicated that while prevalence rates are projected to decline slightly, incidence rates are expected to continue rising. Both males and females showed a dip then rise in prevalence trends, but the increase was more pronounced among females. In 2035, the highest number of incident cases is projected to occur in the 65\u201369 age group, whereas the highest incidence rate is predicted in the 95\u2009+\u2009age group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>A concerning upward trend in incidence, DALYs, and deaths related to ILD&amp;PS was observed in the global population aged 55 years and older, particularly among females. To our knowledge, this is the first study to comprehensively analyze the burden of ILD&amp;PS in this age group from 1990 to 2021. Our findings on epidemiological trends and their variations across geography, SDI, age, and sex can inform policy-makers in designing targeted strategies to mitigate the anticipated rise in disease burden.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0347482","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:40:16Z","timestamp":1776706816000},"page":"e0347482","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Global burden, trends and projections analysis of interstitial lung disease and pulmonary sarcoidosis in elderly adults (aged 55+ Years) based on GBD 2021"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9748-9186","authenticated-orcid":true,"given":"Zhilan","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingyi","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuni","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhujin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuliang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0909-5557","authenticated-orcid":true,"given":"Wei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"issue":"6","key":"pone.0347482.ref001","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"WD Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"issue":"10354","key":"pone.0347482.ref002","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(22)01052-2","article-title":"Interstitial lung diseases","volume":"400","author":"M Wijsenbeek","year":"2022","journal-title":"Lancet"},{"issue":"8","key":"pone.0347482.ref003","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline","volume":"201","author":"ED Crouser","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"pone.0347482.ref004","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2213-2600(18)30064-X","article-title":"Pulmonary sarcoidosis","volume":"6","author":"P Spagnolo","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"11","key":"pone.0347482.ref005","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra2101555","article-title":"Challenges of sarcoidosis and its management","volume":"385","author":"M Drent","year":"2021","journal-title":"N Engl J Med"},{"issue":"9","key":"pone.0347482.ref006","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jama.2022.1570","article-title":"Diagnosis and Treatment of Pulmonary Sarcoidosis: A Review","volume":"327","author":"JA Belperio","year":"2022","journal-title":"JAMA"},{"key":"pone.0347482.ref007","doi-asserted-by":"crossref","first-page":"1466029","DOI":"10.3389\/fimmu.2024.1466029","article-title":"Identification and validation of hub differential genes in pulmonary sarcoidosis","volume":"15","author":"Q Yao","year":"2024","journal-title":"Front Immunol"},{"issue":"16","key":"pone.0347482.ref008","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168952","article-title":"Fibrotic Idiopathic Interstitial Lung Disease: The Molecular and Cellular Key Players","volume":"22","author":"AV Samarelli","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"25","key":"pone.0347482.ref009","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1056\/NEJMc2031135","article-title":"Spectrum of Fibrotic Lung Diseases","volume":"383","author":"L Salvati","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0347482.ref010","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1164\/rccm.201006-0894CI","article-title":"Clinical course and prediction of survival in idiopathic pulmonary fibrosis","volume":"183","author":"B Ley","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pone.0347482.ref011","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12931-021-01791-z","article-title":"Global incidence and prevalence of idiopathic pulmonary fibrosis","volume":"22","author":"TM Maher","year":"2021","journal-title":"Respir Res"},{"issue":"9","key":"pone.0347482.ref012","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS\/ERS\/JRS\/ALAT Clinical Practice Guideline","volume":"205","author":"G Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"pone.0347482.ref013","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.chest.2023.11.035","article-title":"Comparison of Pirfenidone and Nintedanib: Post Hoc Analysis of the CleanUP-IPF Study","volume":"165","author":"JS Kim","year":"2024","journal-title":"Chest"},{"issue":"9","key":"pone.0347482.ref014","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.rmed.2013.06.011","article-title":"Safety and efficacy of pirfenidone in idiopathic pulmonary fibrosis in clinical practice","volume":"107","author":"R Okuda","year":"2013","journal-title":"Respir Med"},{"key":"pone.0347482.ref015","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3389\/fmed.2018.00148","article-title":"The Management of Patients With Idiopathic Pulmonary Fibrosis","volume":"5","author":"P Spagnolo","year":"2018","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"pone.0347482.ref016","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S2213-2600(18)30502-2","article-title":"Lung transplantation for idiopathic pulmonary fibrosis","volume":"7","author":"PM George","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"7","key":"pone.0347482.ref017","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1164\/rccm.201905-0958LE","article-title":"Trends in Idiopathic Pulmonary Fibrosis-related Mortality in the United States: 2000-2017","volume":"200","author":"EP Dove","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"pone.0347482.ref018","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1164\/rccm.201902-0467LE","article-title":"The Mortality Burden of Idiopathic Pulmonary Fibrosis in the United Kingdom","volume":"200","author":"V Navaratnam","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"10258","key":"pone.0347482.ref019","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"issue":"10440","key":"pone.0347482.ref020","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"issue":"6","key":"pone.0347482.ref021","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/thoraxjnl-2020-216732","article-title":"Global and regional burden of interstitial lung disease and pulmonary sarcoidosis from 1990 to 2019: results from the Global Burden of Disease study 2019","volume":"77","author":"X Ma","year":"2022","journal-title":"Thorax"},{"key":"pone.0347482.ref022","doi-asserted-by":"crossref","first-page":"1141372","DOI":"10.3389\/fmed.2023.1141372","article-title":"Global trends of interstitial lung diseases from 1990 to 2019: an age-period-cohort study based on the Global Burden of Disease study 2019, and projections until 2030","volume":"10","author":"Q Zeng","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"pone.0347482.ref023","doi-asserted-by":"crossref","first-page":"103026","DOI":"10.1016\/j.janxdis.2025.103026","article-title":"Burden of anxiety disorders among older adults aged \u2265\u00a055 years in 204 countries and territories, 1990\u20132021: A population-based study","volume":"113","author":"B Wang","year":"2025","journal-title":"J Anxiety Disord"},{"issue":"10440","key":"pone.0347482.ref024","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"issue":"4","key":"pone.0347482.ref025","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1097\/JS9.0000000000001071","article-title":"Global, regional, and national burden of inguinal, femoral, and abdominal hernias: a systematic analysis of prevalence, incidence, deaths, and DALYs with projections to 2030","volume":"110","author":"F Wang","year":"2024","journal-title":"Int J Surg"},{"issue":"10258","key":"pone.0347482.ref026","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S0140-6736(20)30677-2","article-title":"Fertility, mortality, migration, and population scenarios for 195 countries and territories from 2017 to 2100: a forecasting analysis for the Global Burden of Disease Study","volume":"396","author":"SE Vollset","year":"2020","journal-title":"Lancet"},{"issue":"10159","key":"pone.0347482.ref027","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories","volume":"392","author":"KJ Foreman","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"pone.0347482.ref028","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202005-2032ST","article-title":"Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS\/JRS\/ALAT Clinical Practice Guideline","volume":"202","author":"G Raghu","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"pone.0347482.ref029","doi-asserted-by":"crossref","first-page":"146","DOI":"10.7861\/clinmedicine.17-2-146","article-title":"Update in diagnosis and management of interstitial lung disease","volume":"17","author":"TA Mikolasch","year":"2017","journal-title":"Clin Med (Lond)"},{"key":"pone.0347482.ref030","volume-title":"World Population Prospects 2022: Summary of Results","author":"Division UDoEaSAP","year":"2022"},{"key":"pone.0347482.ref031","volume-title":"World population prospects 2022: methodology of the United Nations population estimates and projections","author":"Division UDoEaSAP","year":"2022"},{"key":"pone.0347482.ref032","volume-title":"World health statistics 2023: monitoring health for the SDGs, sustainable development goals","author":"World Health O","year":"2023"},{"issue":"12","key":"pone.0347482.ref033","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1164\/rccm.202007-2794OC","article-title":"Outcome of hospitalization for COVID-19 in patients with interstitial lung disease. An international multicenter study","volume":"202","author":"TM Drake","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"pone.0347482.ref034","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1164\/rccm.202006-2441LE","article-title":"Increased odds of death for patients with interstitial lung disease and COVID-19: a case-control study","volume":"202","author":"AJ Esposito","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pone.0347482.ref035","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/s41467-023-37193-6","article-title":"Telomere length associates with chronological age and mortality across racially diverse pulmonary fibrosis cohorts","volume":"14","author":"A Adegunsoye","year":"2023","journal-title":"Nat Commun"},{"issue":"2","key":"pone.0347482.ref036","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1164\/rccm.201902-0451OC","article-title":"Grp78 Loss in Epithelial Progenitors Reveals an Age-linked Role for Endoplasmic Reticulum Stress in Pulmonary Fibrosis","volume":"201","author":"Z Borok","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"pone.0347482.ref037","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-physiol-021119-034610","article-title":"Aging and lung disease","volume":"82","author":"SJ Cho","year":"2020","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"pone.0347482.ref038","article-title":"Pulmonary rehabilitation for interstitial lung disease","volume":"2","author":"L Dowman","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"pone.0347482.ref039","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/rccm.200701-044OC","article-title":"Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003","volume":"176","author":"AL Olson","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"pone.0347482.ref040","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.chest.2017.11.023","article-title":"Current Concepts in Pathogenesis, Diagnosis, and Management of Smoking-Related Interstitial Lung Diseases","volume":"154","author":"A Kumar","year":"2018","journal-title":"Chest"},{"issue":"10159","key":"pone.0347482.ref041","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/S0140-6736(18)32225-6","article-title":"Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"pone.0347482.ref042","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1164\/rccm.201904-0717ST","article-title":"The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement","volume":"199","author":"PD Blanc","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"pone.0347482.ref043","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1164\/rccm.201906-1250OC","article-title":"Income and Other Contributors to Poor Outcomes in U.S. Patients with Sarcoidosis","volume":"201","author":"LJ Harper","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"pone.0347482.ref044","doi-asserted-by":"crossref","first-page":"333","DOI":"10.31128\/AJGP-02-23-6713","article-title":"Unravelling the health and economic burden of interstitial lung diseases in adults in Australia","volume":"53","author":"IA Cox","year":"2024","journal-title":"Aust J Gen Pract"},{"issue":"5","key":"pone.0347482.ref045","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.chest.2022.12.039","article-title":"Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia","volume":"163","author":"D Assayag","year":"2023","journal-title":"Chest"},{"issue":"1","key":"pone.0347482.ref046","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12890-020-01297-2","article-title":"Australasian interstitial lung disease registry (AILDR): objectives, design and rationale of a bi-national prospective database","volume":"20","author":"I Moore","year":"2020","journal-title":"BMC Pulm Med"},{"issue":"6","key":"pone.0347482.ref047","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1164\/rccm.201607-1484OC","article-title":"Interstitial Lung Disease in India. Results of a Prospective Registry","volume":"195","author":"S Singh","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"pone.0347482.ref048","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.21037\/jtd-19-4021","article-title":"The interstitial lung disease spectrum under a uniform diagnostic algorithm: a retrospective study of 1,945 individuals","volume":"12","author":"B Guo","year":"2020","journal-title":"J Thorac Dis"},{"issue":"10309","key":"pone.0347482.ref049","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0140-6736(21)01826-2","article-title":"Treatment of fibrotic interstitial lung disease: current approaches and future directions","volume":"398","author":"KA Johannson","year":"2021","journal-title":"Lancet"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0347482","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:40:25Z","timestamp":1776706825000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0347482"}},"subtitle":[],"editor":[{"given":"Yoshiaki","family":"Zaizen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,20]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0347482","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]}}}